These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 22675173)

  • 81. Nasal natural killer/T-cell lymphoma and its association with type "i"/XhoI loss strain Epstein-Barr virus in Chile.
    Cabrera ME; Eizuru Y; Itoh T; Koriyama C; Tashiro Y; Ding S; Rey S; Akiba S; Corvalan A
    J Clin Pathol; 2007 Jun; 60(6):656-60. PubMed ID: 16775124
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Circulating cell-free and Epstein-Barr virus DNA in pediatric B-non-Hodgkin lymphomas.
    Machado AS; Da Silva Robaina MC; Magalhães De Rezende LM; Apa AG; Amoêdo ND; Bacchi CE; Klumb CE
    Leuk Lymphoma; 2010 Jun; 51(6):1020-7. PubMed ID: 20470219
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.
    Meerbach A; Wutzler P; Häfer R; Zintl F; Gruhn B
    J Med Virol; 2008 Mar; 80(3):441-54. PubMed ID: 18205222
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.
    Omar H; Hägglund H; Gustafsson-Jernberg A; LeBlanc K; Mattsson J; Remberger M; Ringdén O; Sparrelid E; Sundin M; Winiarski J; Yun Z; Ljungman P
    Transpl Infect Dis; 2009 Oct; 11(5):393-9. PubMed ID: 19497070
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Classification of cell lineage and anatomical site, and prognosis of extranodal T-cell lymphoma -- natural killer cell, cytotoxic T lymphocyte, and non-NK/CTL types.
    Ohshima K; Liu Q; Koga T; Suzumiya J; Kikuchi M
    Virchows Arch; 2002 Apr; 440(4):425-35. PubMed ID: 11956825
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Establishment of real-time polymerase chain reaction-based assay for quantitation of Epstein-Barr virus DNA in healthy donors and in patients with EBV associated lymphoma.
    Incomserb P; Bhattarakosol P; Kulwichit W; Chantratita W; Hansasuta P
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S280-6. PubMed ID: 16623042
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection.
    Bauer CC; Aberle SW; Popow-Kraupp T; Kapitan M; Hofmann H; Puchhammer-Stöckl E
    J Med Virol; 2005 Jan; 75(1):54-8. PubMed ID: 15543583
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Ganciclovir is associated with low or undetectable Epstein-Barr virus DNA load in cerebrospinal fluid of patients with HIV-related primary central nervous system lymphoma.
    Bossolasco S; Falk KI; Ponzoni M; Ceserani N; Crippa F; Lazzarin A; Linde A; Cinque P
    Clin Infect Dis; 2006 Feb; 42(4):e21-5. PubMed ID: 16421782
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Early radiotherapy has an essential role for improving survival in patients with stage I-II nasal-type of NK/T cell lymphoma treated with L-asparaginase-containing chemotherapy--a single institution experience.
    Zang J; Li C; Luo SQ; Wang JH; Xu M; Zhao LN; Li WW; Yang H; Xiao F; Hitchcock YJ; Shi M
    Ann Hematol; 2015 Apr; 94(4):583-91. PubMed ID: 25409913
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Diagnosis and management of natural killer-cell malignancies.
    Ishida F; Kwong YL
    Expert Rev Hematol; 2010 Oct; 3(5):593-602. PubMed ID: 21083476
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Epstein-Barr virus DNA quantification and follow-up in Tunisian nasopharyngeal carcinoma patients.
    Hassen E; Farhat K; Gabbouj S; Bouaouina N; Abdelaziz H; Chouchane L
    Biomarkers; 2011 May; 16(3):274-80. PubMed ID: 21506698
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Early response to high-dose methotrexate, vincristine, and procarbazine chemotherapy-adapted strategy for primary CNS lymphoma: no consolidation therapy for patients achieving early complete response.
    Kim YR; Kim SH; Chang JH; Suh CO; Kim SJ; Kim Y; Hwang DY; Jang JE; Hyun SY; Cheong JW; Min YH; Kim JS
    Ann Hematol; 2014 Feb; 93(2):211-9. PubMed ID: 23903866
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Nasal-type extranodal natural killer/T-cell lymphoma presenting with extensive leg ulcers.
    Chia HY; Tey HL; Tan KB; Chong WS
    Clin Exp Dermatol; 2009 Dec; 34(8):e693-5. PubMed ID: 20055838
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Chemorefractory extranodal nasal-type natural-killer/T-cell lymphoma with great response to pembrolizumab in a young patient: a case report.
    Adabifirouzjaei F; Khazai B; Azami G; Shoja-E-Razavi G
    J Med Case Rep; 2021 Oct; 15(1):539. PubMed ID: 34702349
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Relationship of immunosuppression to Epstein-Barr viral load and lymphoproliferative disease in pediatric heart transplant patients.
    Schubert S; Renner C; Hammer M; Abdul-Khaliq H; Lehmkuhl HB; Berger F; Hetzer R; Reinke P
    J Heart Lung Transplant; 2008 Jan; 27(1):100-5. PubMed ID: 18187094
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Nasopharyngeal extranodal NK/T-cell lymphoma, nasal type: retrospective study of 18 consecutive cases in Guangzhou, China.
    Huang YH; Wu QL; Zong YS; Feng YF; Hou JH
    Int J Surg Pathol; 2011 Feb; 19(1):51-61. PubMed ID: 21134987
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Bone marrow that is positive for Epstein-Barr virus encoded RNA-1 by in situ hybridization is related with a poor prognosis in patients with extranodal natural killer/T-cell lymphoma, nasal type.
    Huang WT; Chang KC; Huang GC; Hsiao JR; Chen HH; Chuang SS; Chen TY; Su WC; Tsao CJ
    Haematologica; 2005 Aug; 90(8):1063-9. PubMed ID: 16079105
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Extranodal nasal type NK/T-cell lymphoma: the expression of Epstein-Barr virus latent membrane protein 1 and its significance of prognosis].
    Zhao S; Liu WP; Zhang WY; Li GD
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 May; 36(3):338-40. PubMed ID: 15931862
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Serum survivin and vascular endothelial growth factor in extranodal NK/T-cell lymphoma, nasal type: implications for a potential new prognostic indicator.
    Kim SJ; Hong M; Do IG; Lee SH; Ryu KJ; Yoo HY; Hong JY; Ko YH; Kim WS
    Haematologica; 2015 Mar; 100(3):e106-9. PubMed ID: 25480498
    [No Abstract]   [Full Text] [Related]  

  • 100. Unrelated bone marrow transplantation for Epstein-Barr virus-associated T/NK-cell lymphoproliferative disease.
    Okamura T; Kishimoto T; Inoue M; Honda M; Yamashita N; Wakiguchi H; Yagita M; Hosoi G; Sako M; Yasui M; Yagi K; Kawa K
    Bone Marrow Transplant; 2003 Jan; 31(2):105-11. PubMed ID: 12621491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.